PAMAfrica

Portfolio approach to developing the next-generation of malaria treatments for Africa

Resources

1

Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa

Prescription patterns and compliance with World Health Organization recommendations for the management of uncomplicated and severe malaria: A prospective, real-world study in sub-Saharan Africa

Malaria Journal

Peer-reviewed article

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Evolution of Pfdhps and Pfdhfr mutations before and after adopting seasonal malaria chemoprevention in Nanoro, Burkina Faso

Scientific Reports

Peer-reviewed article

PAMAfrica training initiatives: 2020–2023

PAMAfrica training initiatives: 2020–2023

An infographic detailing the training initiatives undertaken through PAMAfricas Work Package 4: Building research capacity in Africa

PAMAfrica results presentation and publication policy

The policy for the presentation and publication of PAMAfrica results outlines the role of the PAMAfrica Publications Committee, and the responsibilities of the committee, publication authors, sponsors and the PAMAfrica Grant Management Team as they relate to disseminating consortia results and publications

PAMAfrica Publications Committee

Report: 3rd Annual PAMAfrica Consortium meeting

Hosted in Paris, France, on the margins of the EDCTP Forum, the 3rd PAMAfrica Annual Consortium Meeting revolved around Work Package progress, status and outlook, with a deeper dive into capacity building, focusing on the PhD and MSc students.

PAMAfrica and SINDOFO annual meeting report

The PAMAfrica & SINDOFO back-to-back annual meetings took place at CERMEL’s facility in Lambaréné, Gabon from 20 to 22 September. The objective was to share progress and future plans per work package, with discussions on selected topics.

Meet PAMAfrica students

Report - 1st Annual PAMAfrica Consortium meeting

Photo: AJackson/iStock

Safety, pharmacokinetics, and antimalarial activity of the novel plasmodiumeukaryotic translation elongation factor 2 inhibitor M5717

A first-in-human, randomised, placebo-controlled, double-blind, single ascending dose study and volunteer infection study.

The Lancet Infectious Diseases

Peer-reviewed article

Photo: Dtimiraos/iStock

Efficacy of Cipargamin (KAE609) in a Randomized, Phase II Dose-Escalation Study in Adults in Sub-Saharan Africa With Uncomplicated Plasmodium falciparum Malaria

Clinical Infectious Diseases

Peer-reviewed article

Photo: Ugutmen

High Prevalence of Plasmodium falciparum K13 Mutations in Rwanda Is Associated With Slow Parasite Clearance After Treatment With Artemether-Lumefantrine

The Journal of Infectious Diseases

Peer-reviewed article

A randomized, double-blind, phase 2b study to investigate the efficacy, safety, tolerability and pharmacokinetics of a single-dose regimen of ferroquine with artefenomel in adults and children with uncomplicated Plasmodium falciparum malaria

Malaria Journal

Peer-reviewed article

Pages